Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Freed

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Vaccine|September 28, 2011
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infectionDai Wang, Fengsheng Li, Daniel C Freed, et al.
Vaccines|October 2, 2019
Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing PlacentasTakako Tabata, Matthew Petitt, June Fang-Hoover, et al.
Human Vaccines & Immunotherapeutics|March 18, 2016
Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirusAdam C Finnefrock, Daniel C Freed, Aimin Tang, et al.
Virology Journal|April 10, 2020
Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cellsYing Qi, Li He, Xiaohong Cui, et al.
Annals of Epidemiology|January 20, 2016
Deployment, combat, and risk of multiple physical symptoms in the US military: a prospective cohort studyPhoebe K McCutchan, Xian Liu, Cynthia A LeardMann, et al.
Contemporary Clinical Trials Communications|April 30, 2019
Impact of financial reimbursement on retention rates in military clinical trial research: A natural experiment within a multi-site randomized effectiveness trial with active duty service membersLaura A Novak, Bradley E Belsher, Michael C Freed, et al.
Journal of Virology|December 19, 2000
Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virusT M Fu, D C Freed, W L Trigona, et al.
Vaccine|January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysTong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Medical Care|April 26, 2016
Mental Health Utilization Patterns During a Stepped, Collaborative Care Effectiveness Trial for PTSD and Depression in the Military Health SystemBradley E Belsher, Lisa H Jaycox, Michael C Freed, et al.
Vaccine|December 2, 2021
Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primatesHualin Li, Morgan A Monslow, Daniel C Freed, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Vaccine|September 28, 2011
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infectionDai Wang, Fengsheng Li, Daniel C Freed, et al.
Vaccines|October 2, 2019
Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing PlacentasTakako Tabata, Matthew Petitt, June Fang-Hoover, et al.
Human Vaccines & Immunotherapeutics|March 18, 2016
Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirusAdam C Finnefrock, Daniel C Freed, Aimin Tang, et al.
Virology Journal|April 10, 2020
Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cellsYing Qi, Li He, Xiaohong Cui, et al.
Annals of Epidemiology|January 20, 2016
Deployment, combat, and risk of multiple physical symptoms in the US military: a prospective cohort studyPhoebe K McCutchan, Xian Liu, Cynthia A LeardMann, et al.
Contemporary Clinical Trials Communications|April 30, 2019
Impact of financial reimbursement on retention rates in military clinical trial research: A natural experiment within a multi-site randomized effectiveness trial with active duty service membersLaura A Novak, Bradley E Belsher, Michael C Freed, et al.
Journal of Virology|December 19, 2000
Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virusT M Fu, D C Freed, W L Trigona, et al.
Vaccine|January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysTong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Medical Care|April 26, 2016
Mental Health Utilization Patterns During a Stepped, Collaborative Care Effectiveness Trial for PTSD and Depression in the Military Health SystemBradley E Belsher, Lisa H Jaycox, Michael C Freed, et al.
Vaccine|December 2, 2021
Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primatesHualin Li, Morgan A Monslow, Daniel C Freed, et al.
Pageof 13